Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

NSF Funding Innovation Research, Collaboration, Training

(NASA)

National Science Foundation (NSF) has begun a new funding program, Accelerating Innovation Research, with two related activities to help accelerate the translation of new knowledge from research into products with market value. The activities aim to spur translation of fundamental research, to encourage collaboration between academia and industry, and to train students . . . → Read More: NSF Funding Innovation Research, Collaboration, Training

Energy Department to Fund Nanolubricant Plant

(National Renewable Energy Laboratory)

The U.S. Department of Energy (DoE) has awarded NanoMech Inc. of Springdale, Arkansas a grant for $1 million to develop and test a pilot-scale production facility for manufacturing of NanoGlide, the company’s lubricant additives engineered at nano scale. The DoE grant is a Phase 2 Small Business Innovation Research . . . → Read More: Energy Department to Fund Nanolubricant Plant

Small Business Grant Awarded for Oral Hygiene Drug

PolyMedix Inc., a biotechnology company in Radnor, Pennsylvania received a $986,000 Phase 2 small business grant from National Institutes of Health (NIH). The grant supports development of antimicrobial compounds for the treatment of oral candidiasis, a yeast infection affecting the lining of the mouth or tongue, through 31 August 2012.

Under the first portion of . . . → Read More: Small Business Grant Awarded for Oral Hygiene Drug

Trial Shows Genital Herpes Vaccine Ineffective for Women

The National Institute of Allergy and Infectious Diseases (NIAID), part of National Institutes of Health in Bethesda, Maryland, reports that an experimental vaccine to prevent genital herpes disease in women, proved ineffective when tested in a recently concluded clinical trial.

GlaxoSmithKline (GSK) Biologicals, based in Belgium, developed the vaccine it calls Simplirix. GSK announced today . . . → Read More: Trial Shows Genital Herpes Vaccine Ineffective for Women

NIST Develops Standard Cigarette for Fire Safety Testing

(A. Kotok)

Makers of home furnishings need to test their products for fire resistance, and the National Institute of Standards and Technology (NIST) in Gaithersburg, Maryland has come up with a tool to help: a cigarette. A responsibility of NIST, an agency of the U.S. Department of Commerce, is development of standard reference . . . → Read More: NIST Develops Standard Cigarette for Fire Safety Testing

Sanofi-aventis, Covance to Partner on Drug Development

Covance Inc., a drug development services company in Princeton, New Jersey, announced today an agreement with French pharmaceutical company Sanofi-aventis to provide drug development services to Sanofi-aventis over the next 10 years, with payments ranging from $1.2 billion to $2.2 billion.

As part of the agreement, Sanofi-aventis will sell its Porcheville, France and Alnwick, United . . . → Read More: Sanofi-aventis, Covance to Partner on Drug Development

Grant Awarded for Natural Invasive Mussel Control

Hoover Dam water intakes on the Colorado River (A. Kotok)

National Science Foundation awarded Marrone Bio Innovations Inc. of Davis, California $600,000 in grants for naturally-based biotechnologies to control invasive mussels. The funding includes a $500,000 Small Business Technology Transfer Program grant for the project Commercialization of an Innovative Green Technology for Controlling . . . → Read More: Grant Awarded for Natural Invasive Mussel Control

Biotech Company, Universities Produce Artificial Spider Silk

Matured silkworm (University of Notre Dame)

A joint R&D project by University of Notre Dame in South Bend, Indiana, University of Wyoming in Laramie, and Kraig Biocraft Laboratories Inc. in Lansing, Michigan has succeeded in producing transgenic (genetically engineered) silkworms capable of spinning artificial spider silks.

Natural spider silks have a number of . . . → Read More: Biotech Company, Universities Produce Artificial Spider Silk

Process Validated for Purifying Protein-Based Drugs

(Rensselaer Polytechnic Institute)

Scientists at Rensselaer Polytechnic Institute in Troy, New York, are using nuclear magnetic resonance to understand and improve the process of purifying drugs that use proteins, which are notoriously difficult to separate from other potentially deadly impurities.

A team led by Steven Cramer, professor of polymer engineering at Rensselaer studied . . . → Read More: Process Validated for Purifying Protein-Based Drugs

Study: Wisconsin Benefits from Bioscience Industry

A study by Bioforward, an association of biotechnology companies in Wisconsin, shows a growing bioscience industry with high-paying jobs over the past few years, in contrast to other industries in the state. The analysis covers the period of 2004 through 2009.

The bioscience industry, as defined by Bioforward, includes employers in four industry sub-sectors: agricultural . . . → Read More: Study: Wisconsin Benefits from Bioscience Industry